SoftBank Vision Fund $1.1 billion investment in Roivant Sciences

9/8/2017

Financial investment

Value:

$ 1.1 billion

Status:

Completed

Date:

9/8/2017

Overview:

The SoftBank Vision Fund has made a $1.1 billion equity investment in healthcare therapy developer Roivant Sciences.
SoftBank first launched the fund in May 2017.
The Vision Fund invests in technology companies in a variety of sectors.

Kurt Stumpo - Journalist

Jurisdictions:

United States
Bermuda
Japan
Switzerland
United Kingdom

Deal type:

Financial investment

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Cooley

Party: SoftBank Vision Fund (Investor)

Lawyer: Matthew Bartus

Walkers

Party: SoftBank VIsion Fund (Investor)

Related deals